tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
Advertisement

Kymera Therapeutics (KYMR) Similar Stocks

Compare
373 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kymera Therapeutics
$57.21
$4.02B
32.31%
17 Buy
0 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$87.00
$4.06B
94.08
92.99%
12 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$25.12
$3.15B
-7.44%
10 Buy
7 Hold
1 Sell
Moderate Buy
Crinetics Pharmaceuticals
$44.93
$4.18B
-15.45%
15 Buy
1 Hold
0 Sell
Strong Buy
Akero Therapeutics
$53.88
$3.72B
81.84%
3 Buy
7 Hold
0 Sell
Moderate Buy
MoonLake Immunotherapeutics
$10.26
$584.50M
-78.17%
8 Buy
8 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KYMR
Kymera Therapeutics
57.21
12.19
27.08%
PTGX
Protagonist Therapeutics
87.00
41.92
92.99%
APLS
Apellis Pharmaceuticals
25.12
-2.02
-7.44%
CRNX
Crinetics Pharmaceuticals
44.93
-8.21
-15.45%
AKRO
Akero Therapeutics
53.88
24.25
81.84%
MLTX
MoonLake Immunotherapeutics
10.26
-38.68
-79.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis